# Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage

> **NCT03419923** · NA · UNKNOWN · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 141 (estimated)

## Conditions studied

- Hemodialysis
- Anticoagulation

## Interventions

- **DRUG:** two stage regional citrate
- **DRUG:** one stage regional citrate

## Key facts

- **NCT ID:** NCT03419923
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-10
- **Primary completion:** 2019-03-30
- **Final completion:** 2019-03-30
- **Target enrollment:** 141 (ESTIMATED)
- **Last updated:** 2018-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03419923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03419923, "Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03419923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*